![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Richter A.
Publisher: Elsevier
ISSN: 0014-2999
Source: European Journal of Pharmacology, Vol.458, Iss.1, 2003-01, pp. : 107-110
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
NR2B subtype-selective NMDA receptor antagonists: 2001 – 2004
Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 4, 2005-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
NR2B Selective NMDA Receptor Antagonists
Current Pharmaceutical Design, Vol. 8, Iss. 10, 2002-05 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)